Correlation Between Blueprint Medicines and Revolution Medicines
Can any of the company-specific risk be diversified away by investing in both Blueprint Medicines and Revolution Medicines at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Blueprint Medicines and Revolution Medicines into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Blueprint Medicines Corp and Revolution Medicines, you can compare the effects of market volatilities on Blueprint Medicines and Revolution Medicines and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Blueprint Medicines with a short position of Revolution Medicines. Check out your portfolio center. Please also check ongoing floating volatility patterns of Blueprint Medicines and Revolution Medicines.
Diversification Opportunities for Blueprint Medicines and Revolution Medicines
0.51 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Blueprint and Revolution is 0.51. Overlapping area represents the amount of risk that can be diversified away by holding Blueprint Medicines Corp and Revolution Medicines in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Revolution Medicines and Blueprint Medicines is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Blueprint Medicines Corp are associated (or correlated) with Revolution Medicines. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Revolution Medicines has no effect on the direction of Blueprint Medicines i.e., Blueprint Medicines and Revolution Medicines go up and down completely randomly.
Pair Corralation between Blueprint Medicines and Revolution Medicines
Given the investment horizon of 90 days Blueprint Medicines is expected to generate 4.26 times less return on investment than Revolution Medicines. In addition to that, Blueprint Medicines is 1.05 times more volatile than Revolution Medicines. It trades about 0.06 of its total potential returns per unit of risk. Revolution Medicines is currently generating about 0.27 per unit of volatility. If you would invest 4,386 in Revolution Medicines on August 27, 2024 and sell it today you would earn a total of 1,364 from holding Revolution Medicines or generate 31.1% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Blueprint Medicines Corp vs. Revolution Medicines
Performance |
| Timeline |
| Blueprint Medicines Corp |
| Revolution Medicines |
Blueprint Medicines and Revolution Medicines Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Blueprint Medicines and Revolution Medicines
The main advantage of trading using opposite Blueprint Medicines and Revolution Medicines positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Blueprint Medicines position performs unexpectedly, Revolution Medicines can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Revolution Medicines will offset losses from the drop in Revolution Medicines' long position.| Blueprint Medicines vs. Eliem Therapeutics | Blueprint Medicines vs. HCW Biologics | Blueprint Medicines vs. Scpharmaceuticals | Blueprint Medicines vs. Milestone Pharmaceuticals |
| Revolution Medicines vs. Blueprint Medicines Corp | Revolution Medicines vs. Sana Biotechnology | Revolution Medicines vs. Kymera Therapeutics | Revolution Medicines vs. Monte Rosa Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Other Complementary Tools
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |